PATENT CLAIM ANALYSIS

Application Number: 15761146
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "052000"]

Abstract:
Vitamin B12 for use in the treatment of a condition in a subject is administered sublingually. The vitamin B12 is dispersed in a hydrophobic continuous phase, such as oil or fat. The condition to be treated is vitamin B12 deficiency.

Claim (Index 2):
Vitamin B12 according to  claim 1 , wherein the hydrophobic continuous phase is chosen from at least one of i) fat, ii) fatty acids, and iii) wax.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.41935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14647914', '14226661', '11776329', '14227707', '11579527']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608445005071811
- 35 USC 102 Novelty (BERT): 0.4754602578977047
- Combined Prediction Score: 0.7323060762462336
- Mean Citation Score: 162.694774
- Max Citation Score: 172.43538
- Similarity Product: 130.09748399736642

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test